Chou, Hong-Shiue
, M.D. 
Institution: Linkou Chang Gung Memorial Hospital
Position: Attending Physican, Department of General Surgery, Liver transplantation Surgery.
Office Address: No.5, Fuxing St., Guishan , Taoyuan County 333, Taiwan
Tel:886-3-3281200 ext.3632
E-mail: chouhs@adm.cgmh.org.tw 
Focus of Interest:- Transplant immunology
- Laparoscopic surgery
- Hepatobilliary surgery
- Liver transplantation
- Small bowel transplantation
Employment Record:2011.7-present Assistant professor, attending doctor
2010.9-2010.6 Attending Doctor
Division of General Surgery, Department of Surgery, Chang-Gung Memorial Hospital at Linkou
2008.9-2010.8 Post-doctoral fellow, Department of immunology, Lerner Research Institute, Cleveland clinic, USA
2005.8-2008.8 Attending Doctor Division of General Surgery, Department of Surgery, Chang-Gung Memorial Hospital at Linkou
2004.8-2005.7 Attending Doctor Division of General Surgery,Department of Surgery, Chang-Gung Memorial Hospital at Keelung
2001.8-2004.7 General Surgical Resident, Division of General Surgery, Department of Surgery, Chang-Gung Memorial Hospital at Linkou
1999.8-2001.7 Surgical Resident, Department of Surgery, Department of Surgery, Chang-Gung Memorial Hospital at Linkou
1996.7-1997.6 Intern, Shin-Kong ,Wu Ho-Su Memorial Hospital, Taipei city
Education:1990.9-1997.6 Taipei Medical College (Curretly, Taipei Medical University), Taipei city
1987.9-1990.6 Municipal Kaoshiung Senior High School, Kaohsiung city
Full Publication List
Honor & Awards：1. 92 year Linkou Chang Gung Memorial Hospital excellent teaching residency.
2. Finalist of the 2009 of F.Merlin Bumpus, Ph.D Junior Investigator Award in Basic Science, Cleveland Clinic, 2009
3. Mentee/Mentor Travel Award for the XXIII International Congress of the Transplantation Society, 2010
4. 100 annual Linkou Chang Gung Memorial Hospital excellent teachers.
5. 100 in the second half of the Chang Gung Memorial Hospital, excellent medical records.
6. 101 Annual Linkou Chang Gung Memorial Hospital excellent teachers.
7. 102 Annual Linkou Chang Gung Memorial Hospital excellent teachers.
8. 102 in the second half of the Chang Gung Memorial Hospital,excellent medical records.
Board Certification:1.Taiwan Surgical Association, No. 0049444
2.Taiwan surgical society of Gastroenterology No.1124
3.Taiwan association of endoscopic surgery No.D0275
4.Critical care, Taiwan Surgical Association, No.0254
Professional activity:1. 2007- present 擔任10A病房主任
2. 2008- present 擔任病房委員會委員
3. 2012- present 擔任開刀房委員會委員
4. 2012年醫院評鑑外科病房負責人
5. 2012年負責外科部JCIA評鑑委員
6. 2013年負責JCIA 評鑑ACC 小組委員
7. 擔任OSCE國考考官四次(101-102-4/27 8hr in台大醫院; 102-5-10 4小時in 萬芳醫院, 103-4-27, 103-5-2 in CGMH) 及院內外科OSCE考官多次
8. 指導捷克交換學生(101-8. Tereza Ondorva)(102-8.Kystina. )
9. 2012年擔任實習醫師導師(謝孟玲、杜穎純)
10. 2013年擔任實習醫師導師五位 (李怡穎、林杰緯、徐偉倫、陳怡如、劉彥君)
11. 2013 年一般外科教育委員。
12. 2013/7/27 PGY 導師訓練營在澄清醫院
13. 2013/8 PGY 導生江孟軒。董秀蓉，王信堯，簡偉哲，姚硯博
14. 2014/2 接外科部醫教委員及實習醫師負責人
Licensers:
Chinese Medical License NO: 030060
Professional Affiliations:
◎2003 Taiwan Surgical Association
◎2004 Taiwan surgical society of Gastroenteroloy
◎2004 Breast cancer society of Taiwan
◎2004 The transplantation society of Taiwan
◎2006 The society of ultrasound in medicine, R.O.C
◎2006 Taiwan association of endoscopic surgery
◎2007人體試驗主持人考試合格主01580號
◎2010 The Transplantation Society (International)
◎2012 (101)台醫教學會OSCE考官證字第1459號
Research Project:Principle investigator:
1. The impact of Myeloid Derived Suppressor Cells in Islet Transplantation. Procotol No. CMRPG3A1241. 2012-2014
Co-investigator:
1. PRG-XL (Liver Study): A Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf (tacrolimus)/MMF, and Extended Release (XL)Tacrolimus/MMF and Steroid withdrawal in denovo Liver Transplant Recipients. Protocol No. PRGXLLTx-0701-2-TW; 2007-2010; Astellas
2. Oral thalidomide and Tegafur-uracil to decrease hepatocellular carcinoma recurrent after hepatectomy in high risk patients- A phase II study. TTY biopharm. 2008-2012
3. PATRON study: A prospective, randomized, double-blind, placebo controlled, parallel-group, international multicenter phase III trial of PI-88 in the adjuvant treatment of subjects with hepatitis virus related hepatocellular carcinoma after surgical resection. Protocol No. CT-PI-31; Medigen Biotechnology Corporation, 2009-2012
4. A Randomized, Placebo-controlled, Double-blind phase 2 Study of Second-line Treatment with OSI-906 in Patinets with Advanced Hepatocellular Carcinoma(HCC) after Failure of First line Treatment with Sorafenid. Protocol No. OSI-906-206; Astellas, 2012